On December 24, US President Joe Biden signed into law the National Defense Authorization Act (NDAA) for the Fiscal Year 2023, which contains several provisions to deal with China's growing assertiveness and provide support to Taiwan.
Union Minister said that Prime Minister Narendra Modi's caravan is at a rapid pace and Rahul Gandhi won't be able to replace him. "If we (NDA) are winning above 400 seats in 2024, how can Rahul Gandhi become the Prime Minister?" he said.
Senators overwhelmingly passed the National Defence Authorization Act (NDAA) on Thursday, with sending the bill to US President Joe Biden to be signed into law, The Hill newspaper reported.
New Delhi [India], November 24 (ANI/SRV): To simplify learning and empower every student to unleash their maximum potential, need to dive deep into Comprehensive Exam Strategy with Last Minute Tips to Crack the Exam. One of the biggest and toughest exams in India, the UPSC NDA & NA 2023
Speaking to ANI, Sangma said, "We will go alone in the upcoming election of the state. We had fought alone in earlier elections also. But our support to NDA will be continued. Out of 60 assembly seats of Meghalaya, as of now, we have finalized our party candidates in 58 seats."
The last rites of the deceased colonel will take place at his native place- Ghanau Sadulpur village in the district Churu of Rajasthan's Jaipur on Friday.
According to the sources, the police are likely to call the victim's father for DNA testing after which the blood sample and bone sample will be sent to Forensic Light Source (FLS) for matching. The FSL will then conduct a DNA test.
Rajnath Singh said the NDA government declassified and dedicated to people of the country, more than 300 documents related to Netaji Subhas Chandra Bose that were not brought to the public domain for a very long time.
BJP won 11 seats while its ally party Asom Gana Parishad (AGP) won one seat. While on the other side, the major opposition in the state, Congress, bagged two seats and 8 seats have been won by Independents.
SPARC submitted a new drug application (NDA) to the US Food and Drug Administration (US FDA) for this product for the treatment of seizures in newborns in February 2022, according to Sun Pharma statement shared with stock exchanges.